Skip to content
OpenCapital
Get started

Kewaunee Scientific Corporation KEQU Cash & Equivalents

Cash & Equivalents at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$3.28B-21.4%
WAT
Waters CorporationWAT
$462M+20.7%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$188.67M-46.9%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$272.91M+656%
Lifetime Brands logo
Lifetime BrandsLCUT
$13.86M+33.6%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$14.1M-26.8%

Other financials

Income statement

See full
Revenue$71.4M-7.5%
Gross profit$21.2M-11.6%
Operating income$5.2M-38.6%
Net income$3.4M-30.1%
EPS (diluted)$1.13-30.7%

Balance sheet

See full
Total debt$25.3M+6.6%
Total equity$74.7M+15.9%
Total assets$178.3M-8.4%

Cash flow

See full
Operating cash flow$5.5M-42.0%
CapEx$928.0K+79.8%
Free cash flow$4.5M-49.0%

Valuation

See full
Market cap$101.96M-34.8%
Enterprise value$117.3M-28.0%
P/E10.6×-3.1×
P/S0.4×-0.3×

Profitability

See full
Gross margin28.5%-0.1pp
Operating margin5.9%-1.5pp
Net margin3.4%-1.3pp
FCF margin5.2%—

Returns & leverage

See full
Return on equity13.8%-5.3pp
Debt / equity0.3×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by Kewaunee Scientific Corporation in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Kewaunee Scientific Corporation’s 10-K, filed June 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kewaunee Scientific Corporation's cash & equivalents?
Kewaunee Scientific Corporation (KEQU) reported cash & equivalents of $9.95M in Q1 2026.
How has Kewaunee Scientific Corporation's cash & equivalents changed year-over-year?
Kewaunee Scientific Corporation's cash & equivalents decreased by 42.0% year-over-year, from $17.16M to $9.95M.
What is the long-term trend for Kewaunee Scientific Corporation's cash & equivalents?
Over 5 years (2021 to 2026), Kewaunee Scientific Corporation's cash & equivalents has grown at a 11.7% compound annual growth rate (CAGR), from $5.73M to $9.95M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.